Literature DB >> 12476350

CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Davide Ragozzino1.   

Abstract

Chemokines and their receptors are constitutively present in the central nervous system (CNS), expressed in neurons and glial cells. Much evidence suggests that, beyond their involvement in neuroinflammation, these proteins play a role in neurodevelopment and neurophysiological signaling. The goal of this review is to summarize recent information concerning expression, signaling, and function of CXC chemokine receptor in the CNS, with the main focus on the developmental and neuromodulatory actions of chemokines in the cerebellum.

Mesh:

Substances:

Year:  2002        PMID: 12476350     DOI: 10.1080/13550280290100932

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  131 in total

Review 1.  Recent excitement in the ionotropic glutamate receptor field.

Authors:  E B Ziff
Journal:  Ann N Y Acad Sci       Date:  1999-04-30       Impact factor: 5.691

2.  Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells.

Authors:  D Nguyen; M Stangel
Journal:  Brain Res Dev Brain Res       Date:  2001-05-31

3.  Mode and tempo of tangential cell migration in the cerebellar external granular layer.

Authors:  H Komuro; E Yacubova; E Yacubova; P Rakic
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 4.  The cells and molecules that make a cerebellum.

Authors:  D Goldowitz; K Hamre
Journal:  Trends Neurosci       Date:  1998-09       Impact factor: 13.837

5.  Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells.

Authors:  Y Ohtani; M Minami; N Kawaguchi; A Nishiyori; J Yamamoto; S Takami; M Satoh
Journal:  Neurosci Lett       Date:  1998-06-19       Impact factor: 3.046

6.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

Authors:  Q Ma; D Jones; P R Borghesani; R A Segal; T Nagasawa; T Kishimoto; R T Bronson; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 7.  Chemokine receptors.

Authors:  R Horuk
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

8.  Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS.

Authors:  R S Klein; K C Williams; X Alvarez-Hernandez; S Westmoreland; T Force; A A Lackner; A D Luster
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

9.  Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum.

Authors:  Davide Ragozzino; Massimiliano Renzi; Aldo Giovannelli; Fabrizio Eusebi
Journal:  J Neuroimmunol       Date:  2002-06       Impact factor: 3.478

10.  SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum.

Authors:  C Limatola; A Giovannelli; L Maggi; D Ragozzino; L Castellani; M T Ciotti; F Vacca; D Mercanti; A Santoni; F Eusebi
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

View more
  19 in total

Review 1.  Neural immunity: Friend or foe?

Authors:  Howard E Gendelman
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  Chemokines: integrators of pain and inflammation.

Authors:  Fletcher A White; Sonia K Bhangoo; Richard J Miller
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

Review 3.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

4.  Localization of CXCR4 in the forebrain of the adult rat.

Authors:  Jordan Trecki; G Cristina Brailoiu; Ellen M Unterwald
Journal:  Brain Res       Date:  2009-12-21       Impact factor: 3.252

5.  Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders.

Authors:  Stephanie A Ballendine; Quentin Greba; Wojciech Dawicki; Xiaobei Zhang; John R Gordon; John G Howland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-12       Impact factor: 5.067

6.  Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis.

Authors:  Muhammad Z Khan; Renato Brandimarti; Jeegar P Patel; Nha Huynh; Jun Wang; Ziwei Huang; Alessandro Fatatis; Olimpia Meucci
Journal:  AIDS Res Hum Retroviruses       Date:  2004-10       Impact factor: 2.205

7.  An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction.

Authors:  Merril Gersten; Mehrdad Alirezaei; Maria Cecilia Garibaldi Marcondes; Claudia Flynn; Timothy Ravasi; Trey Ideker; Howard S Fox
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

8.  CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.

Authors:  Silvia Di Prisco; Guendalina Olivero; Elisa Merega; Tommaso Bonfiglio; Mario Marchi; Anna Pittaluga
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-05       Impact factor: 4.147

9.  Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.

Authors:  Saadet Inan; Toby K Eisenstein; Mia N Watson; Menahem Doura; Joseph J Meissler; Christopher S Tallarida; Xiaohong Chen; Ellen B Geller; Scott M Rawls; Alan Cowan; Martin W Adler
Journal:  J Pharmacol Exp Ther       Date:  2018-09-24       Impact factor: 4.030

10.  NF-kappaB mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons.

Authors:  Rui-Hua Yang; Judith A Strong; Jun-Ming Zhang
Journal:  Mol Pain       Date:  2009-05-28       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.